Scientists test 'Living Drug' to reset immune system in MS patients
Disease control
Not yet recruiting
This early-stage study is testing a new personalized therapy called CABA-201 for adults with multiple sclerosis (MS) that hasn't responded well to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target the cells thought to drive MS, an…
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC